Consolidated Balance Sheets - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents	$ 38,449,000	$ 34,766,000
Accounts receivable, net	76,000	133,000
Inventories	3,923,000
Interest receivable	6,000	1,000
Other current assets	6,689,000	740,000
Total Current Assets	49,143,000	35,640,000
Inventories	709,000
Restricted cash	0	250,000
Property and equipment, net	4,408,000	3,120,000
Intellectual property, net	46,898,000	2,241,000
In-process research and development	16,511,000
Goodwill	130,869,000	93,842,000
Other long term assets	64,000	18,000
Total Assets	248,602,000	135,111,000
Current Liabilities
Accounts payable	4,450,000	1,768,000
Accrued expenses	7,395,000	1,769,000
Contingent consideration - current portion	12,500,000
Notes payable - current portion	6,727,000	610,000
Total Current Liabilities	31,072,000	4,147,000
Long Term Liabilities
Contingent consideration - less current portion	11,000,000
Net deferred tax liabilities	16,263,000
Notes payable - less current portion, net of debt discount	12,990,000	9,175,000
Total Liabilities	$ 71,325,000	$ 13,322,000
Commitments and Contingencies
Stockholders' Equity
Common stock $0.001 par value, 750,000,000 shares authorized at December 31, 2015 and 2014; 100,180,872 and 63,182,806 shares issued at December 31, 2015 and December 31, 2014, respectively; and 100,149,453 and 63,182,806 shares outstanding at December 31, 2015 and December 31, 2014, respectively	$ 100,000	$ 63,000
Additional paid-in capital	363,280,000	257,642,000
Accumulated deficit	(182,864,000)	(135,916,000)
Treasury stock at cost, 31,419 and 0 shares at December 31, 2015 and December 31, 2014, respectively	(73,000)
Accumulated other comprehensive loss	(3,166,000)
Total Stockholders' Equity	177,277,000	121,789,000
Total Liabilities and Stockholders' Equity	$ 248,602,000	$ 135,111,000